Carlumab (CNTO 888) 是一种具有高亲和力的人源化抗
CCL2(趋化因子配体 2) 抗体。Carlumab 可用于癌症，尤其是前列腺癌的研究。
| 生物活性 |
Carlumab (CNTO 888) is a humanised anti-CCL2(chemokine ligand 2) antibody with high affinity. Carlumab can be used incancerresearch, particularly in prostatecancer[1].
|
| IC50& Target |
|
| Clinical Trial |
|
| CAS 号 |
|
| Sequence |
B21505606百英货号，100 mg 15000元；张雪要求上线20220919
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis.
|
m.cnreagent.com
